Table 1.
Reference | Sample Description | Surgeries | Assessment and Rate of Delirium | Drugs Studied | P-Valuesab | Odds | ||
---|---|---|---|---|---|---|---|---|
Prospective Observational Studies | ||||||||
Santos et al., [5] | Average age = 71 yrs n = 220 | Non-emergency CABG on CPB | DSM-IV, 33.6% | Collected data on preoperative use of diuretics, CCBs, b-blockers, ACEIs, nitrates, PPIs; anesthetic premedication with either diazepam or midazolam | Diuretics CCBs b-blockers ACEIs Nitrates PPIs Diazepam |
0.080 0.518 0.179 0.088 0.632 0.865 <0.05 |
NA | |
Objective: To determine risk factors for delirium after CABG | ||||||||
Rudolph et al., [7] | Average age = 74 yrs n = 42 |
CABG, valve replacement, combined CABG-valve surgery on CPB | MMSE, DSI, MDAS, CAM, 29% | Collected data on preoperative use of aspirin, NSAIDs, steroids, b-blockers, ACEIs, ARBs, CCBs, nitrates, diuretics | NA (but reported no significant differences in preoperative medication use between patients with and without delirium) |
NA | ||
Objective: To compare changes in the levels of inflammatory markers in patients with and without delirium after cardiac surgery | ||||||||
Afonso et al., [10] | Average age = 66 yrs n = 112 |
Cardiac or thoracic aortic surgeries on CPB | RASS, CAM-ICU, 34% | Collected data on preoperative use of nitratesc, benzodiazepines, SSRIs and ACEIs |
ACEI |
0.91 | NA | |
Objective: To produce a predictive model for delirium after cardiac surgery | ||||||||
Katznelson et al., [22] |
Average age = NA (36% were < 60 yrs old, and 64% were ³ 60 yrs old) n = 1,059 |
CABG, valve replacements, combined CABG-valve replacement surgery on CPB | CAM-ICU, 11.5% | Looked at preoperative use of statins and perioperative benzodiazepine and opioid use | Statin | <0.01 |
Statin |
Odds Ratiod (95% CI) 0.54 (0.35-0.84) |
Objective: To demonstrate an association between preoperative statin use and delirium after cardiac surgery | ||||||||
Tan et al., [25] | Average age = 63 yrs n = 53 |
CABG, valve replacements, combined CABG-valve surgery on CPB | CAM, MDAS, MMSE, 23% | Collected data on preoperative ‘chemical dependency’; and use of ‘other’; anticholinergic medications (neither variable was defined); also recorded postoperative morphine equivalents over POD 1-3 |
Chemical dependency ‘Other’; anti-cholinergic agents Morphine equivalents, POD 1-3 |
0.18 0.10 0.76 |
‘Other’; anticholinergic agents Morphine equivalents, POD 1-3 |
Risk Ratio (95% CI) 2.31 (0.85-6.31) 1.00 (0.99-1.01) |
Objective: To determine factors associated with and rate of delirium after cardiac surgery | ||||||||
Prospective Observational Studies | ||||||||
Tully et al., [27] | Average age = 65 yrs n = 158 |
Elective CABG, combined CABG-valve surgery on CPB | DSI, DSM-IV-TR, 31% | Collected data on preoperative use of anticholinergic drugs, SSRIs, tricyclic antidepressants | Anticholinergic drugs SSRI Tricyclic antidepressant Composite of drugs (anticholinergics, SSRIs, and/or tricyclics) |
0.31 0.01 0.65 0.01 |
Composite of drugs |
Odds Ratio (95% CI) 5.12 (1.46-17.94) |
Objective: To determine an association between preoperative affective disorders or Type D personality with delirium after cardiac surgery | ||||||||
Koster et al., [29] | Average age = 70 yrs n = 112 |
Elective cardiac surgery with or without CPB | DOS, DSM-IV, 21% | Collected data on preoperative opioid use | Opioids | 1.00 | NA | |
Objective: To determine the predictive validity of a risk checklist for delirium after cardiac surgery | ||||||||
Norkiene et al., [51] | Average age = 71 yrs n = 1,367 |
CABG on CPB | DSM-IV, 3.1% | Collected data on postoperative use of inotropes for more than 12 hours | Inotropes > 12hrs | 0.002 |
Inotropes > 12hrs |
Odds Ratio (95% CI) 8.04 (1.1-60.6) |
Objective: To identify the incidence and risk factors for delirium after cardiac surgery | ||||||||
Retrospective Chart Review | ||||||||
Redelmeier et al., [24] | Average age = 74 yrs n = 284,158 |
Elective cardiac, thoracic, neurosurgical, vascular, musculoskeletal, abdominal, retroperitoneal, lower urogenital, breast and skin, external head and neck, ophthalmologic, and unclassified surgeries | ICD, 1.1% | Outpatient use of two or more of: atorvastatin, simvastatin, pravastatin, lovastatin, fluvastatin, rosuvastatin, and/or cerivastatin, with at least one having been prescribed within 90-days before surgery; also preoperative neuropsychiatric agents, nonstatin lipid-lowering agents, antihypertensives, loop diuretics, cardiovascular agents, anticoagulants, vascular agents, other common drugs |
Statins Cholinesterase inhibitor Antipsychotic Antidepressant Benzodiazepine ACEI ARB Thiazide diuretic CCB Furosemide Digoxin Spironolactone Nonstatin lipid-lowering agent Anticoagulant Antiplatelet Pentoxifylline Hypoglycemics Insulin Bronchodilator Allopurinol Levothyroxine Glucocorticoid Gastric acid suppressant Anti-osteoporosis Glaucoma eye drops |
< 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.43 0.77 0.29 0.21 0.71 0.60 0.59 0.21 0.16 0.95 0.44 0.57 0.59 0.34 0.10 0.99 0.56 0.80 0.89 0.39 |
Statins Cholinesterase inhibitor Antipsychotic Antidepressant Benzodiazepine ACEI ARB Thiazide diuretic CCB Furosemide Digoxin Spironolactone Nonstatin lipid-lowering agent Anticoagulant Antiplatelet Pentoxifylline Hypoglycemic Insulin Bronchodilator Allopurinol Levothyroxine Glucocorticoid Gastric acid suppressant Anti-osteoporosis Glaucoma eye drops |
Odds Ratioe (95% CI) 1.28 (1.12-1.46)f 3.99 (2.26-7.05) 1.57 (1.26-1.95) 2.01 (1.75-2.25) 1.40 (1.28-1.53) 0.96 (0.87-1.06) 1.05 (0.73-1.52) 0.92 (0.79-1.07) 0.94 (0.85-1.04) 1.03 (0.89-1.18) 0.96 (0.83-1.11) 1.09 (0.80-1.47) 0.80 (0.56-1.14) 1.14 (0.95-1.38) 1.01 (0.68-1.52) 1.16 (0.80-1.69) 0.96 (0.83-1.11) 0.93 (0.73-1.20) 1.06 (0.94-1.20) 0.83 (0.67-1.03) 1.00 (0.88-1.14) 0.94 (0.77-1.15) 0.99 (0.90-1.08) 1.01 (0.86-1.18) 0.94 (0.80-1.09) |
Objective: To determine if the use of statins was associated with a higher rate of delirium after cardiac and non-cardiac surgeries | ||||||||
Post-Hoc Analysis of a Randomized Controlled Trial | ||||||||
Burkhart et al., [11] | Average age = 74 yrs n = 113 |
Elective cardiac surgery with CPB | CAM, 30% | Collected data on preoperative use of statins; intraoperative amount of fentanyl; postoperative use of metoclopramide and tropisteron, and postoperative amount of opioids received per kilogram of body weight | Statins Fentanyl dose, per 10-µg/kg increase Opioid dose, per 1-mg/kg increase |
0.8 0.006 0.6 |
Statins Fentanyl dose, per 10-µ>g/kg increase Opioid dose, per 1-mg/kg increase |
Odds Ratio (95% CI) 1.1 (0.49-2.48) 3.4 (1.41-8.14) 1.5 (0.29-8.18) |
Objective: To identify modifiable risk factors for delirium after cardiac surgery | ||||||||
Randomized Controlled Trial (Open-Label, Treatment-Controlled) | ||||||||
Maldonado et al., [3] | Average age = 58 yrs n = 90 |
Elective valve procedures on CPB | DSM-IV-TR, Overall rate, 34% Dexmedeto-midine cohort, 3% Propofol cohort, 50% Midazolam cohort, 50% |
Compared rate of delirium with postoperative sedation by dexmedetomidine to sedation by propofol, or midazolam (in each sedation protocol, also looked at differences in intraoperative amount of fentanyl and midazolam, postoperative amount of fentanyl and total morphine equivalents, and postoperative use of antiemetics, lorazepam, and haloperidol) |
Dexmedetomidine/propofol/midazolam Midazolam/dexmedetomidine Propofol/dexmedetomidine |
< 0.001 <0.001 <0.001 |
Midazolam (vs. dexmedetomidine) Propofol (vs.dexmedetomidine) |
Odds Ratiog (95% CI) 28.6 (4.7-262.5) 29.6 (4.8-280.6) |
Objective: To determine the effects of postoperative sedation on delirium after cardiac surgery | ||||||||
Randomized Controlled Trial (Double-Blind, Treatment-Controlled) | ||||||||
Shehabi et al., [26] | Average age = 71 yrs n = 299 |
CABG, valve replace- ments, combined CABG-valve surgery on pump |
CAM-ICU, Overall rate, 11.7% Dexmedetomidine cohort, 8.6% Morphine cohort, 15% |
Compared rate of delirium with postoperative sedation by dexmedetomidine to sedation by morphine (used open-label morphine in dexmedetomidine group to titrate for analgesia and open-label propofol in morphine group to titrate for sedation) |
Dexmedetomidine/ morphine | 0.088 |
Dexmedetomidine (vs. morphine) |
Risk Ratio (95% CI) 0.57 (0.26-1.1)h |
Objective: To compare the incidence of delirium in patients postoperatively sedated with dexmedeto- midine or morphine after cardiac surgery | ||||||||
Randomized Controlled Trials (Double-Blind, Placebo-Controlled) | ||||||||
Prakanrattana and Prapaitrakool, [6] | Average age = 61 yrs n = 126 |
Elective cardiac surgery on CPB | CAM-ICU, Risperidone cohort, 11.1% Placebo cohort, 31.7% |
Investigated the effectiveness of postoperative risperidone prophylaxis (one dose of 1 mg risperidone or placebo immediately upon awakening from sedation in the ICU) | Risperidone/ placebo | 0.009 |
Risperidone (vs. placebo) |
Risk Ratio (95% CI) 0.35 (0.16-0.77) |
Objective: To evaluate the efficacy of immediate postoperative risperidone for prevention of delirium after cardiac surgery | ||||||||
Gamberini et al., [8] | Average age = 74 yrs n = 113 |
CABG, valve replace- ments, with or without CPB |
CAM, Rivastigmine cohort, 32% Placebo cohort, 30% |
Investigated the effectiveness of a rivastigmine prophylaxis regimen (3 doses of 1.5 mg o.d. rivastigmine or placebo starting on evening before surgery until POD 6) | Rivastigmine/ placebo |
0.8 |
Rivastigmine (vs. placebo) |
Risk Ratio (95% CI) 1.08 (0.62 -1.90) |
Objective: To evaluate the efficacy of rivastigmine prophylaxis regimen for the prevention of delirium after cardiac surgery | ||||||||
Hudetz et al., [9] | Average age = 64 yrs n = 58 |
Elective CABG, valve replacements, valve repairs on CPB | Intensive Care Delirium Screening Checklist (based on DSM-IV), Ketamine cohort, 3% Placebo cohort, 31% |
Investigated the effectiveness of intraoperative ketamine for prophylaxis (0.5 mg/kg i.v. ketamine or 0.9% saline placebo during anesthetic induction along with fentanyl and etomidate) | Ketamine/placebo | 0.01 |
Placebo (vs. ketamine) |
Odds Ratio (95% CI) 12.6 (1.5-107.5) |
Objective: To evaluate the efficacy of intraoperative ketamine for the prevention of delirium after cardiac surgery |
CABG, coronary artery bypass graft surgery; CPB, cardiopulmonary bypass; DSM-IV-(TR), diagnostic and statistical manual of mental disorders fourth, (text-revised) edition; CCB, calcium channel blocker; ACEI angiotensin-converting enzyme inhibitor; PPI, proton-pump inhibitor; MMSE, mini-mental state examination; DSI, delirium symptom interview; MDAS, memorial delirium assessment scale; CAM-(ICU), confusion assessment method (intensive care version); NSAID, non-steroidal anti-inflammatory drug; ARB, angiotensin receptor II blocker; RASS, Richmond agitation-sedation scale; SSRI, selective serotonin reuptake inhibitor; CI, confidence interval; POD postoperative day; DOS, delirium observation screening scale; ICD, international classification of diseases; ICU, intensive care unit; o.d., omne in die; i.v., intravenously; NA, not available
With respect to delirium after surgery
Calculated based on the proportions of patients on these drugs, unless otherwise specified
Did not analyze preoperative nitrates, benzodiazepines or SSRIs because only one patient was taking each of these drugs
Adjusted for age, preoperative depression, preoperative renal dysfunction, complex cardiac surgery, perioperative intra-aortic balloon pump, and massive blood transfusion
Adjusted for age, sex, duration of surgery, individual medications, and type of surgery
Adjusted for age, sex, social status, prior admissions, duration of surgery, individual medications, type of surgery
Adjusted for other sedatives, age, ASA score (American Society of Anesthesiologists Physical Status Classification System score), male sex
While Shehabi et al. [26] failed to find a statistically significant difference in the incidence of delirium between morphine- and dexmedetomidine-treated patients, they did find that compared to delirious morphine-treated patients, dexmedetomidine patients who did become delirious had shorter durations of delirium (p = 0.0317), were extubated earlier (p = 0.04), had fewer episodes of systolic hypotension (p=0.006), required less norepinephrine (p = <0.001), but had more bradycardia (p = 0.006).